Account Info
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GMVDW G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM) > Key Indicators
GMVDW G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM)
0.8840.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle（D）
89.12% -37.7461 -4.03% -261.4571 -- -261.4571 -262.05% -346.8059
Receivable Turnover（T）
15.42% 7.0388 7.36% 8.2647 -- 8.2647 81.32% 6.0986
Inventory Turnover（T）
-81.75% 7.4773 -11.65% 15.982 -- 15.982 432.49% 40.9765
Fixed Assets Turnover（T）
-40.19% 1.5589 47.07% 2.4867 -- 2.4867 99.57% 2.6065
Total Asset Rate（T）
-30.28% 0.3169 -8.07% 0.6336 -- 0.6336 -1.81% 0.4545
ROA
-73.11% -168.849% -4.50% -186.485% -- -186.485% 25.41% -97.538%
Efficiency Ratios
ROA 5 Year Average
-- -- -- -144.223% -- -- -- --
Profitability Ratios TTM
Gross Margin
-360.75% -104.567% 118.15% 29.696% -- 29.696% 289.77% 40.103%
Operating Margin
-204.38% -609.433% 19.00% -198.438% -- -198.438% 13.11% -200.224%
Net Margin
-148.31% -532.821% -13.67% -294.346% -- -294.346% 24.04% -214.583%
EBITDA Margin
-83.78% -3.2474% -4.25% -1.7867% -- -1.7867% 21.01% -1.767%
R & D Expense Ratio
143.13% 51.640% 23.73% 33.210% -- 33.210% 2,135.79% 21.240%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% 13.87% 178.030% -- 178.030% -- 0.000%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-- -- -- -- -- -- -- 12.019%
Total Assets to Common Equity
-- -- -- -- -- -- -- 509.769%
Debt to Asset Ratio
-- -- -- -- -- -- -- 86.797%
Current Ratio
-63.30% 0.5576 160.24% 1.0326 -- 1.0326 477.15% 1.5196
Quick Ratio
-77.90% 0.3212 327.92% 0.8476 -- 0.8476 685.67% 1.4532
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More
CEO： Dr. Yacov Geva
Market： NASDAQ
Listing Date： 06/25/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist